Emerging treatments for metastatic castration-resistant prostate cancer: Immunotherapy, PARP inhibitors, and PSMA-targeted approaches
- Resource Type
- Article
- Source
- In
Cancer Treatment and Research Communications 2020 23 - Subject
- Language
- ISSN
- 2468-2942